醫用聚甲醛 (POM) 市場 - 2023 年至 2028 年預測

2021年醫用聚甲醛（POM）市場規模為47,912,000美元。

醫用聚甲醛（通常稱為 POM 或乙縮醛）是一種高性能工程熱塑性塑料，用於醫療行業的各種應用。 由於其獨特的性能，如高剛度、更高的尺寸穩定性和低摩擦係數，它越來越多地被製藥和生物技術公司用於醫療器械製造過程。 最常用的醫用聚甲醛是共聚物POM和均聚物POM。 均聚物 POM 由單一類型的單體製成，由同一分子的重複組成，因此具有高機械和熱性能以及高結晶度和剛度。 相比之下，共聚物 POM 是由兩種不同類型的單體製成的聚合物。 醫用聚甲醛主要用於製造透析器、吸入器、醫療托盤、手術器械手柄、胰島素筆和藥物瓶蓋。

由於POM是一種可回收材料，由於環保意識的提高，醫療保健行業對可持續材料的需求不斷增加，醫用POM的需求也在不斷增加。 一些醫療器械製造商正在將回收的 POM 融入其產品中，以減少對環境的影響。 此外，醫療保健支出和基礎設施的增長、醫療設備需求的增加以及高級醫用 POM 生產新興市場的開發預計將導致預測期內醫用聚甲醛市場的擴張。

醫療設備和設備的需求不斷增長正在推動醫療 POM 市場的增長。

POM 由於其耐化學品和生物製劑而被廣泛用於製造需要經常清潔和滅菌的醫療器械。 印度品牌資產基金會預計，2021年印度醫療器械行業規模將達到120億美元，出口額約為25.3億美元。 此外，印度醫療器械行業預計，印度醫療器械進口額將從2021年的4470.8億盧比增至2022年的6320億盧比，增長41%。 醫用 POM 具有高度生物相容性，因為它們不會對人體組織造成任何不良或毒性反應，並且可回收，越來越多地被醫療保健公司使用。 因此，醫用 POM 支持市場增長。

產品提供

• Celanex Corporation 的 Celanex POM：塞拉尼斯公司是美國一家全球領先的化學和特種材料公司，以 Celanex 品牌生產醫用聚甲醛 (POM)。 Celanex POM 是一種高性能熱塑性塑料，用於各種醫療應用，其性能滿足醫療公司對熱塑性聚酯的要求。
• 巴斯夫的 Ultraform POM：巴斯夫是一家國際化學公司，通過其 Ultraform 產品線生產醫用級聚甲醛 (POM)。 巴斯夫提供醫用級 Ultraform POM，它滿足 ISO 10993 等各種監管要求，是一種廣泛應用於醫療應用的高性能熱塑性塑料。
• 恩欣格塑料(Ensinger Plastics) 的TECAFORM POM：恩欣格塑料(Ensinger Plastics) 是一家德國公司，生產各種高性能工程塑料，包括醫用聚甲醛，其中包括具有增強莖桿滅菌抗性的TECAFORM POM。馬蘇。 該公司還為醫療行業客戶提供技術支持和專業知識，以優化 Tecaform POM 在其產品中的使用，包括材料選擇、設計優化和產品開發。

在醫用聚甲醛市場中，按類型劃分，共聚物 POM 預計將佔據較大份額。

由於存在環氧乙烷等第二單體，共聚物 POM 的結晶度比均聚物 POM 低，並且具有更高的衝擊強度，以及增強的耐化學性和高溫耐久性。 因此，共聚物 POM 的有益特性有望增加其在醫用 POM 市場中的份額。

從應用來看，對胰島素筆的需求不斷增長預計將在預測期內擴大醫用 POM 市場。

周圍糖尿病患者數量的不斷增加以及對胰島素筆作為有效的糖尿病護理和治療選擇的需求不斷增加，正在推動對醫用 POM 的需求。 例如，國際糖尿病聯合會估計，過去10年，全球糖尿病的年患病率為3%。 此外，預計全球糖尿病患者總數將從 2021 年的 5.365 億增加到 2045 年的 7.832 億。 由於糖尿病患者人數的增加，胰島素筆的使用也在增加。 醫用級 POM 通常用於胰島素筆製造，因為它具有獨特的性能，可以承受頻繁使用和其他處理步驟。 此外，醫用 POM 即使暴露在不同的溫度和壓力下也能保持其形狀，確保筆的正常功能並防止胰島素盒洩漏或損壞。

北美對醫用聚甲醛市場貢獻顯著，預計在預測期內將大幅增長。

該地區是製造醫療設備的國際醫療和製藥公司的所在地，不斷增長的消費者醫療保健支出正在推動該地區的醫療 POM 市場。 例如，美國醫學會估計，2021年美國醫療保健支出將達到42551億美元。 此外，由於患者腎功能衰竭的增加，對透析機的需求不斷增長，預計將增加醫用 POM 的消耗量。 美國腎臟基金會估計，大約有 570,000 名患者使用透析機，腎衰竭發生率的上升將增加對透析機的需求。

內容

第一章簡介

• 市場概覽
• 市場定義
• 調查範圍
• 市場細分
• 貨幣
• 先決條件
• 基準年和預測年的時間表

第二章研究方法

• 調查數據
• 調查過程

第 3 章執行摘要

• 研究亮點

第 4 章市場動態

• 市場驅動因素
• 市場製約因素
• 波特五力分析
• 行業價值鏈分析

第 5 章醫用聚甲醛 (POM) 市場：按類型

• 共聚物 POM
• 均聚物 POM

第 6 章醫用聚甲醛 (POM) 市場：按應用分類

• 簡介
• 透析器
• 吸入器
• 醫療托盤
• 手術器械手柄
• 胰島素筆
• 藥品封蓋
• 其他

第七章醫用聚甲醛 (POM) 市場：按地區

• 簡介
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東/非洲
  • 沙特阿拉伯
  • 阿拉伯聯合酋長國
  • 以色列
  • 其他
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印度尼西亞
  • 泰國
  • 台灣
  • 其他

第8章競爭環境與分析

• 主要公司及戰略分析
• 新興公司和市場盈利能力
• 合併、收購、協議和合作
• 供應商競爭力矩陣

第9章公司簡介

• Celanese Corporation
• BASF
• Daicel Corporation
• DuPont de Nemours, Inc.
• Ensinger Plastics
• Polyplastics Global
• Kolon Plastic Inc.
• Barlog Plastics GmbH
• SABIC
• Asahi Kasei Corporation

The medical polyoxymethylene (POM) market was valued at US$47.912 million in 2021.

Medical polyoxymethylene, commonly called POM or acetal, is a high-performance engineering thermoplastic used in the medical industry for various applications. Its unique properties, including high stiffness, enhanced dimensional stability, and low friction coefficient, is increasing its consumption by pharmaceutical and biotechnological companies for medical device manufacturing processes. Copolymer POM and homopolymer POM are the most used types of medical polyoxymethylene. Homopolymer POM is made from a single type of monomer that consists of repetitions of the same molecule resulting in a high degree of crystallinity and stiffness in addition to its high mechanical and thermal properties. In contrast, copolymer POM is a polymer made from two different types of monomers. Medical polyoxymethylene is dominantly consumed for manufacturing dialysis machines, inhalers, medical trays, handles for surgical instruments, insulin pens, and pharmaceutical closures.

The growing demand for sustainable materials in the healthcare industry, driven by the awareness of environmental issues, is creating a high demand for medical POM since POM is a recyclable material. Several healthcare equipment manufacturers are incorporating recycled POM into their products to reduce their environmental footprint. Further, the growth in healthcare expenditure and infrastructure, the rise in demand for medical devices, and the developments in the production of advanced grades of medical POM are anticipated to result in the expansion of the medical polyoxymethylene market over the forecast period.

The rise in medical devices and equipment demand is propelling the medical POM market growth.

POM is extensively used to manufacture medical devices that require frequent cleaning and sterilization due to its ability to resist chemical and biological agents. The Indian Brand Equity Foundation estimated that the Indian medical devices sector reached US$12 billion in 2021, with approximately US$2.53 billion worth of exports. Further, the Indian Medical Devices Industry estimated that the number of medical device imports in India increased by 41% to increase from Rs.44,708 crore in 2021 to Rs.63,200 crore in 2022. The biocompatibility of medical POM, since it does not cause harmful or toxic reactions to human tissue and its recyclability, is increasing its consumption by healthcare companies. Therefore, the rising consumption of medical instruments and equipment in most of the world driven by the pandemic and the general rise in the consumption of healthcare facilities by consumers is driving the growth of the medical POM market.

Product Offerings:

• Celanex POM by Celanese Corporation - Celanese Corporation is a leading global chemical and specialty materials company in the US that manufactures medical-grade polyoxymethylene (POM) under its brand, Celanex. Celanex POM is a high-performance thermoplastic used in various medical applications due to its properties to meet the requirements of thermoplastic polyester of medical companies.
• Ultraform POM by BASF -BASF is an international chemical company that produces a range of medical-grade polyoxymethylene (POM) in its Ultraform product line. BASF offers a range of medical-grade Ultraform POM grades that comply with various regulatory requirements, such as ISO 10993, and are high-performance thermoplastics widely used in medical applications.
• TECAFORM POM by Ensinger Plastics - Ensinger Plastics is a German company manufacturing various high-performance engineering plastics, including medical-grade polyoxymethylene as TECAFORM POM with enhanced steam sterilization resistance. In addition, the company provides technical support and expertise to its customers in the medical industry to optimize the use of TECAFORM POM in its products, including material selection, design optimization, and product development.

Copolymer POM is expected to hold a major share of the medical polyoxymethylene market by type.

The presence of the second monomer, such as ethylene oxide, in copolymer POM results in a lower degree of crystallinity and improved impact strength which offers enhanced chemical resistance and durability at higher temperatures than homopolymer POM. Therefore, the beneficial properties of copolymer POM are expected to increase its market share in the medical POM market.

By application, the rising demand for insulin pens is expected to expand the medical POM market over the forecast period.

The rise in the number of people diabetes patients around and the increasing demand for insulin pens as an effective diabetes care and treatment option is increasing the demand for medical POM. For instance, the International Diabetes Federation estimated that the annual prevalence rate of diabetes worldwide is 3% over the last decade. In addition, it is projected that the total number of global diabetes patients will increase from 536.5 million in 2021 to 783.2 in 2045. The rise in diabetic patients is increasing the use of insulin pens. Medical POM is commonly used in manufacturing insulin pens due to its unique properties to withstand frequent usage and other handling processes. In addition, the ability of medical POM to maintain its shape despite its exposure to different temperatures and pressures, which ensures the proper functioning of the pen and prevention of leakage or damage to the insulin cartridge, is resulting in its consumption in insulin pens.

North America contributes majorly to the medical polyoxymethylene market and is expected to grow significantly over the forecast period.

The presence of established international medical and pharmaceutical companies in the region manufacturing medical equipment and the rising healthcare expenditure by consumers is driving the medical POM market in the region. For instance, the American Medical Association estimated that the healthcare expenditure in the US in 2021 amounted to US$4,255.1 billion. Further, the growing demand for dialysis machines driven by the rise in kidney failures among patients is expected to increase the consumption of medical POM. The American Kidney Fund projected that approximately 570,000 patients are on dialysis machines and that the growth rates of kidney failures are expected to augment the demand for dialysis machines.

Market Segmentation:

By Type

• Copolymer POM
• Homopolymer POM

By Application

• Dialysis Machine
• Inhalers
• Medical Trays
• Handles for Surgical Instruments
• Insulin Pen
• Pharmaceutical Closures
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Research Process

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY TYPE

• 5.1. Copolymer POM
• 5.2. Homopolymer POM

6. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Dialysis Machine
• 6.3. Inhalers
• 6.4. Medical Trays
• 6.5. Handles for Surgical Instruments
• 6.6. Insulin Pen
• 6.7. Pharmaceutical Closures
• 6.8. Others

7. MEDICAL POLYOXYMETHYLENE (POM) MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Israel
  • 7.5.4. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. Japan
  • 7.6.3. India
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Taiwan
  • 7.6.8. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

• 9.1. Celanese Corporation
• 9.2. BASF
• 9.3. Daicel Corporation
• 9.4. DuPont de Nemours, Inc.
• 9.5. Ensinger Plastics
• 9.6. Polyplastics Global
• 9.7. Kolon Plastic Inc.
• 9.8. Barlog Plastics GmbH
• 9.9. SABIC
• 9.10. Asahi Kasei Corporation